Treatment group (sirolimus + aflibercept) | Control group (aflibercept monotherapy) | p-value | |
---|---|---|---|
BCVA Change (ETRDS Letters) | 2.5 | 0.8 | 0.42 |
Central Subfield Thickness (μm) | − 54.0 | − 0.1 | 0.28 |
Subretinal Fluid (N) | 9 | 9 | – |
SRF Change (mm3) | − 9.32 | − 3.02 | 0.54 |
Intraretinal Fluid (N) | 4 | 4 | – |
IRF Change (mm3) | − 0.43 | − 0.99 | 0.60 |
Corrected IRF Change (mm3) a | − 1.02 | − 2.48 | 0.59 |
Central 1 mm (N) | 10 | 10 | – |
Foveal Change (mm3) | − 0.49 | − 0.66 | 0.78 |